COVID-19

AMA Update 338: New long COVID clinical trials, FDA approves postpartum depression pill & RSV shot for babies

9 de agosto de 2023 casimedicos 00:10:12 0 Comments

HHS forms the Office of Long COVID Research and Practice, and the NIH launches new Long COVID clinical trials. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses these new Long COVID developments, along with a study with insights into the maternal health crisis in the US and the FDA’s approval of a pill to treat postpartum depression. Plus, NIAID’s new director, the new head of the CDC and ACIP’s RSV shot recommendation for babies. American Medical Association CXO Todd Unger hosts.

🥼 Learn more about the AMA Recovery Plan for America’s Physicians: https://bit.ly/AMA_RecoveryPlan

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

AMA Update 317: RSV vaccine recommendations and ACIP meeting recap with Sandra Fryhofer, MD

27 de junio de 2023 casimedicos 00:16:26 0 Comments

Who should get vaccinated for RSV? What are the side effects and safety concerns for RSV vaccines? Your vaccine questions answered by Sandra Fryhofer, MD — the AMA ACIP liaison and AMA’s immediate past board chair. Dr. Fryhofer shares everything physicians need to know about the new recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for both #RSV vaccines. American Medical Association CXO Todd Unger hosts.

AMA Update 305: 12 symptoms of long COVID, FDA Paxlovid approval & mpox vaccines with Andrea Garcia, JD, MPH

31 de mayo de 2023 casimedicos 00:11:49 0 Comments

A new study outlines the 12 symptoms of long COVID, and the FDA fully approves Paxlovid for adults. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also discusses who should get a monkeypox vaccine ahead of festival season this summer. American Medical Association CXO Todd Unger hosts.
Akiko Iwasaki, PhD, shares what you need to know about long COVID 🦠 Watch here: https://youtu.be/kONtiiHsbPw

AMA Update 302: COVID and RSV vaccines during pregnancy, new mpox vaccine data with Andrea Garcia, JD, MPH

24 de mayo de 2023 casimedicos 00:10:56 0 Comments

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, shares the latest research findings, efficacy and safety concerns for the new RSV vaccine. Also covering recommended vaccines for pregnant peoples, and protecting yourself against monkeypox. American Medical Association CXO Todd Unger hosts.

AMA Update 301: Long COVID: New research, common symptoms, long-term effects and treatments with Akiko Iwasaki, PhD

22 de mayo de 2023 casimedicos 00:16:03 0 Comments

Akiko Iwasaki, PhD, returns to AMA Update to share the latest science behind long COVID, including how many people are still suffering, most common symptoms and what we know about treatments like Paxlovid. She also shares guidance for physicians on diagnosing long COVID, treating post-COVID patients and new research to watch. American Medical Association CXO Todd Unger hosts.

AMA Update 298: CDC Chief Medical Officer Deb Houry, MD, MPH, on the next phase of COVID-19 data, vaccines and care

11 de mayo de 2023 casimedicos 00:12:19 0 Comments

AMA Update welcomes Deb Houry, MD, MPH, chief medical officer and deputy director for program and science at the CDC, to discuss the end of the public health emergency (PHE) and what it means for physicians and patients. Dr. Houry discusses data collection, vaccine coverage and the future of care as we emerge from crisis mode after more than three years. American Medical Association CXO Todd Unger hosts.

The AMA has resources to help with this next phase. Find all you need to know about post-PHE telehealth use, policy, coverage and payment with the AMA Telehealth Quick Guide: https://www.ama-assn.org/practice-management/digital/ama-telehealth-quick-guide

🦠 The U.S. Public Health Emergency for COVID-19 ended May 11, 2023 🦠

AMA Update 293: Mifepristone, latest COVID variants, U.S. public health emergency ending with Andrea Garcia, JD, MPH

3 de mayo de 2023 casimedicos 00:10:51 0 Comments

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares what physicians and patients need to know about the end of the COVID-19 Public Health Emergency on May 11, 2023. Also covering the latest on abortion pill access, XBB.1.16 and XBB.1.9.1 trends, as well as a possible link between conjunctivitis and Arcturus variant. American Medical Association CXO Todd Unger hosts.

AMA Update 289: Second bivalent booster: who should get another COVID shot and when Sandra Fryhofer, MD

25 de abril de 2023 casimedicos 00:13:47 0 Comments

Do you need a second COVID bivalent booster? Get the latest on new COVID vaccine booster recommendations from the CDC and the recent changes to simplify COVID-19 vaccine guidelines from Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP) and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

AMA Update 281: Medicaid eligibility, COVID cases in the U.S., C. auris & Marburg fever with Andrea Garcia, JD, MPH

5 de abril de 2023 casimedicos 00:10:57 0 Comments

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses important changes in Medicaid coverage following the Consolidated Appropriations Act of 2023, coronavirus statistics and reporting slowdowns—as well as the latest on Candida auris and the Marburg fever outbreak. American Medical Association CXO Todd Unger hosts.

AMA Update 277: Candida auris, Marburg virus and latest FDA COVID booster authorizations with Andrea Garcia, JD, MPH

27 de marzo de 2023 casimedicos 00:12:06 0 Comments

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest news physicians need to know, including: tracking the Marburg virus disease (MVD) outbreak, Candida auris symptoms, how sleep can impact vaccine effectiveness, and the FDA’s latest authorization that certain children six months through four years old are now eligible to receive a single booster dose of Pfizer-BioNTech’s updated bivalent shot. American Medical Association CXO Todd Unger hosts.